Allucent Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Allucent's estimated annual revenue is currently $423.7M per year.(i)
  • Allucent's estimated revenue per employee is $201,000

Employee Data

  • Allucent has 2108 Employees.(i)
  • Allucent grew their employee count by -1% last year.

Allucent's People

NameTitleEmail/Phone
1
Chairman and CEOReveal Email/Phone
2
Chairman and CEOReveal Email/Phone
3
Chairman and CEOReveal Email/Phone
4
Chairman and CEOReveal Email/Phone
5
Chief Medical OfficerReveal Email/Phone
6
Chief Medical OfficerReveal Email/Phone
7
Chief Marketing OfficerReveal Email/Phone
8
Chief Financial OfficerReveal Email/Phone
9
Chief Operating Officer & General CounselReveal Email/Phone
10
Chief Revenue OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7M3521%N/AN/A
#2
$3.2M160%N/AN/A
#3
$100.7M5017%N/AN/A
#4
$37.4M18655%N/AN/A
#5
$69.8M2780%$35MN/A
#6
$13.1M655%N/AN/A
#7
$8.2M41-7%N/AN/A
#8
$2.6M130%N/AN/A
#9
$165.7M22714%$250.7MN/A
#10
$27.9M139-10%$637.8KN/A
Add Company

What Is Allucent?

Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. The company is purpose-built through the convergence of leading providers to address this unmet need. Today, Allucent is a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics and clinical pharmacology across a variety of therapeutic areas. With more than 30 years of experience in over 60 countries, Allucent’s individualized partnership approach provides experience-driven insights and expertise to assist its clients in successfully navigating the complexities of delivering novel treatments to patients.

keywords:N/A

N/A

Total Funding

2108

Number of Employees

$423.7M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$553.6M3954N/AN/A
#2
$2586.2M89532%$7.1B
#3
$1290.5M92184%N/A
#4
$5300M942637%N/A
#5
$6066.1M24072N/AN/A